Both of these patients were treated with single agent T-DXd in the absence of surgery or RT for HER2+ BC LM and experienced profound clinical and image-based responses to treatment in their leptomeningeal lesions (Fig. 3 E-F). Here, ERBB2 is linked to breast cancer.